An antibody RRID is a persistent identifier written as RRID:AB_##### that names a specific antibody clone regardless of who sells it. If you’re preparing a manuscript, check the RRID portal or the Antibody Registry now to confirm the identifier before you submit. SciCrunch, the Antibody Registry, and ABMIUM’s own product catalogue are the reference points you’ll return to throughout this process.
Key Takeaways
Citing an antibody correctly requires the RRID, vendor, catalogue number, and lot grouped together at first mention, verified against the Antibody Registry rather than copied from a vendor page.
| Point | Details |
|---|---|
| Search before you cite | Check the RRID portal or Antibody Registry rather than assuming a vendor’s listed RRID is current. |
| Group metadata tightly | Keep vendor, catalogue number, lot, and RRID together in one clause or table row for SciScore and human readers alike. |
| Register missing antibodies promptly | Antibody Registry curators typically respond within about one business day, and registration is free. |
| Solve catalogue switching with RRIDs | The identifier tracks the clone, not the vendor listing, so it survives rebrands and discontinuations. |
| Report validation evidence, not just identity | Publish application-specific validation and check communities like YCharOS or Only Good Antibodies for independent data. |
| Choose RRID-ready sourcing | ABMIUM lists provenance and validation notes alongside catalogue and RRID data on its product pages. |
Table of Contents
- Where to find an RRID for your antibody
- How to cite an antibody RRID in your manuscript
- Registering an antibody that has no RRID yet
- Why RRIDs matter for reproducible research
- Reporting provenance and validation alongside the RRID
- Sourcing RRID-ready antibodies through ABMIUM
- Sources
- FAQ
Where to find an RRID for your antibody
Four places cover almost every search you’ll ever need to run. The RRID portal aggregates records from the community authorities that issue identifiers, so it’s usually the fastest single stop. The Antibody Registry holds the underlying database and lets you download results or query records directly. SciCrunch operates the resolver behind both, meaning a search there often surfaces records the other two miss. The vendor’s own product page is worth checking last, not first, because vendor-listed RRIDs occasionally lag behind registry records after a rebranding or acquisition.
A few search habits save real time:
- Search by vendor name plus catalogue number rather than target name alone.
- Try the clone identifier if the antibody is monoclonal. Clones map to a single RRID even when catalogue numbers change.
- Enter the catalogue number both with and without hyphens. Registry entries aren’t always consistent about formatting.
- If a target-name search returns dozens of hits, add the host species to narrow it down.
A typical effective query looks like this: searching “Chemicon AB1542” on the Antibody Registry returns RRID:AB_90755 directly, with vendor and catalogue metadata attached to the record.
Pro Tip: Never take a vendor-listed RRID at face value. Cross-check it against the Antibody Registry record, and if you need programmatic verification across a large reagent list, query the resolver’s JSON or XML output, or hit the SciCrunch API directly rather than checking each record by hand.
How to cite an antibody RRID in your manuscript
Placement matters more than most authors assume. The convention, laid out in CASRAI’s citation guidance, is to group vendor, catalogue number, lot (where available), and RRID together at first mention, rather than scattering them across a sentence.
A methods-section example: “Cells were stained with anti-CD3 (BioLegend, Cat# 100202, Lot# B361741, RRID:AB_312659).” A reagent table row follows the same logic, just split into columns: Vendor | Catalogue No. | Clone | Lot | RRID.
Before submission, check that every antibody entry includes:
- Vendor name, spelled as the manufacturer lists it.
- Catalogue number, copied exactly, including any letters or suffixes.
- Clone designation, for monoclonals.
- Lot number, if your supply chain tracks it.
- RRID, verified against the registry, not just copied from a vendor page.
Automated screening tools such as SciScore parse reagent citations by looking for this cluster of metadata sitting close together. SciScore’s own documentation notes that scattering vendor and catalogue details away from the RRID increases the risk of a parsing miss, which can trigger an editorial query even when the science is sound.
Grouping metadata isn’t a formatting preference. It’s what lets a machine, not just a human reviewer, confirm which reagent you actually used.
Keep the full string, including the “RRID:” prefix, intact rather than shortening it to just the accession number. Reviewers and automated checkers both expect the full format.
Registering an antibody that has no RRID yet
If your search comes up empty, register the antibody yourself. It’s free, and the record becomes permanent once assigned.
- Go to the Antibody Registry submission form and supply vendor name, catalogue URL, and clone information.
- For lab-made or custom antibodies, attach a datasheet or characterisation summary in place of a vendor URL.
- Submit and wait for curator review.
Curators typically respond within roughly one business day of submission, and once an RRID is assigned it stays resolvable even if the product is later discontinued or the vendor changes hands. A clear catalogue URL and a legible datasheet speed things along considerably, since curators are matching your submission against existing records to avoid duplicates.
Pro Tip: Register the antibody as soon as you notice it’s missing, not the week before submission. Curator turnaround is quick, but manuscript deadlines have a way of colliding with it anyway.
Once assigned, cite the new RRID in your manuscript exactly as you would an existing one, grouped with vendor and catalogue details.
Why RRIDs matter for reproducible research
The core problem RRIDs solve is catalogue switching. A single antibody clone can carry different catalogue numbers depending on which distributor sells it, and vendors merge, rebrand, or discontinue products with some regularity. An RRID stays tied to the clone itself, not the catalogue entry, so a reader tracing your methods years later can still identify the exact reagent even if the original listing has vanished.
This matters because:
- Reproducibility efforts repeatedly cite unclear reagent identification as a recurring obstacle to replicating published results.
- ARRIVE guidelines specifically flag antibodies as key biological resources requiring adequate documentation.
- Persistent identifiers support programmatic resolution through resolver JSON and XML endpoints, letting automated tools like SciScore verify reagent citations at scale rather than relying on manual checking.
An RRID, in effect, is a provenance anchor that survives a reagent’s entire commercial lifecycle.
Reporting provenance and validation alongside the RRID
An RRID confirms identity. It doesn’t confirm the antibody actually works in your hands, for your application, on your species. That’s a separate reporting job, and it’s one reviewers increasingly expect you to do.
Publish this alongside every antibody you report:
- Supplier and catalogue number, plus the RRID itself.
- Clone and lot number.
- The specific application it was validated for (Western blot, IHC, flow cytometry) rather than a generic “validated” claim.
- Any orthogonal validation you ran, such as knockout or knockdown controls.
Before submission, check whether you’ve run any concentration optimisation and noted it, and whether your validation evidence matches the application you actually used the antibody for, not a different one from the datasheet.
For independent, crowd-sourced validation data on specific clones, communities such as YCharOS and the Only Good Antibodies community are worth checking. Both publish orthogonal validation results contributed by working researchers, which is a useful counterweight to vendor datasheets alone. ABMIUM’s own product listings, including entries like the anti-human CD54 antibody, follow this same logic by pairing catalogue and lot information with provenance notes rather than a bare product listing.
Reproducibility isn’t a box you tick with an RRID. It’s a habit of reporting reagent identity, source, and validation evidence together, every time.
A lab-level habit worth adopting
I’d add RRID capture to your reagent log sheet as a required field, not an afterthought filled in at manuscript stage. Make it mandatory on purchase and inventory records too. That single habit catches catalogue switching the moment it happens, rather than months later when you’re writing methods and can’t remember which lot you actually used.
Sourcing RRID-ready antibodies through ABMIUM
Locating the right identifier is only half the job. Sourcing an antibody whose provenance and validation record you can actually trust is the other half, and that’s the gap ABMIUM was built to close. Every product listing on ABMIUM pairs catalogue and lot information with provenance notes, so you’re not left cross-referencing three different pages before you can write a methods sentence.
Take the anti-human TCRVγ9 antibody listing as an example: vendor details, clone designation, and validation notes sit together on the same page, in the same format you’d want for a manuscript’s reagent table. If you’re assembling a reagent list for a new project and want pre-purchase validation rather than a bet on a datasheet, browsing ABMIUM’s catalogue is a reasonable next step, and its independent validation service is there if you need a second opinion on a reagent before you commit lab time to it.
Sources
- RRIDs: Citing antibodies, organisms, software
- SciScore — about
- Antibody Registry — FAQ
- RRID site — getting started
For broader context on reproducible reporting practices beyond reagents, PaperSynapse’s guide to reproducible literature review methodology covers adjacent data practices worth adopting.
FAQ
What is an RRID for an antibody?
An antibody RRID is a persistent, citable identifier formatted as RRID:AB_##### that names a specific antibody clone, independent of which vendor currently sells it.
What does RRID stand for and what is its purpose?
RRID stands for Research Resource Identifier. Its purpose is to give researchers, reviewers, and reproducibility efforts a stable way to identify a reagent, cell line, or organism used in a study, unlike a catalogue number that can change with rebrands.
Where do I search for an antibody’s RRID?
Start with the RRID portal or the Antibody Registry, searching by vendor name plus catalogue number for the fastest match.
What if my antibody has no RRID?
Register it through the Antibody Registry submission form with vendor, catalogue URL, and clone details; curators typically assign an identifier within about one business day.
Does ABMIUM sell antibodies with RRIDs already listed?
ABMIUM’s product pages include catalogue, lot, and provenance information designed to make citing an RRID straightforward, alongside independent validation notes for many listings.